Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy

被引:0
|
作者
Liang, Ze-Yu [1 ]
Wang, Yi-Peng [2 ]
Li, Jing [1 ]
Yang, Wen-Chao [2 ]
Tu, Yong-Fang [2 ]
Zhang, Yue [1 ]
Chen, Song [1 ]
机构
[1] Nankai Univ, Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci,Affiliated, Tianjin 300020, Peoples R China
[2] Anyang Eye Hosp, Anyang 455000, Henan, Peoples R China
关键词
  proliferative diabetic retinopathy; ranibizumab; fibrovascular membranes; glial-mesenchymal transition; microvessel density; ENDOTHELIAL-CELLS; MULLER GLIA; BEVACIZUMAB; EXPRESSION; MARKER; VEGF;
D O I
10.18240/ijo.2022.10.03
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
? AIM: To assess the effects of intravitreal ranibizumab (IVR) on angiogenesis and glial activity of the fibrovascular membrane (FVM) in patients with proliferative diabetic retinopathy (PDR).? METHODS: Forty-two eyes from 42 patients with PDR requiring vitrectomy were included and divided into two groups: control group (n=16) did not receive IVR, while IVR group (n=26) underwent IVR 5d before vitrectomy. FVM specimens were collected by the same surgeon during the interventions. Histopathological morphology was examined by hematoxylin-eosin (H-E) staining and cell densities in the FVM was assessed. Microvessels were outlined by immunohistochemical staining of CD31 and microvessel density (MVD) assessed as an index of FVM angiogenesis. Dual-color immunofluorescence staining, and confocal microscopy was used to detect co-localization and relative expression levels of glial fibrillary acidic protein (GFAP) and alpha-smooth muscle actin (alpha-SMA) as markers of glial-mesenchymal transition (GMT). The GMT index (GI; ratio of relative GFAP/alpha-SMA expression) was used to semi-quantify the degree of GMT or glial activity of FVMs.? RESULTS: H-E staining showed similar vascularization in both groups, with microvessels and scattered stromal cells in the matrix. Infiltrated cell densities did not differ significantly between the two groups (P>0.05). The MVD of the IVR group (130.62 +/- 15.46/mm2) was significantly lower than that of the controls (142.25 +/- 19.16/mm2, P<0.05). In both groups, all sections were strongly immunostained for GFAP and alpha-SMA. The Pearson's correlation coefficients (PCC) of intensity of automated pixel count of two markers indicated GFAP and alpha-SMA co-stained well and GMT participated in the remolding of FVMs in PDR. The mean relative GFAP expression in the IVR group was significantly lower, whereas that of alpha-SMA was significantly higher than in controls (P<0.05). GI in the IVR group (1.10 +/- 0.10) was significantly lower than in the controls (1.21 +/- 0.12, P<0.05).? CONCLUSION: IVR can reduce angiogenesis, glial activity of FVM and promote glial-fibrotic transformation by reducing MVD and promoting GMT but does not decrease the cell density in patients with PDR.
引用
收藏
页码:1577 / 1585
页数:9
相关论文
共 50 条
  • [41] Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
    de Carvalho, Giuliana Ribeiro
    Lima, Vagner Loduca
    da Veiga, Glaucia Luciano
    Adami, Fernando
    Alves, Beatriz da Costa Aguiar
    Pereira, Edimar Cristiano
    Feder, David
    Affonso, Fernando Luiz
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 3149 - 3155
  • [42] Study on the effects of different anti-VEGF drugs on fibrovascular membranes of proliferative diabetic retinopathy
    Wang, Manqiao
    Wang, Linni
    Gong, Yi
    Li, Qingbo
    Shao, Yan
    Li, Xiaorong
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2023, 42
  • [43] Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes
    Klaassen, Ingeborg
    de Vries, Ewout W.
    Vogels, Ilse M. C.
    van Kampen, Antoine H. C.
    Bosscha, Machteld I.
    Steel, David H. W.
    Van Noorden, Cornelis J. F.
    Lesnik-Oberstein, Sarit Y.
    Schlingemann, Reinier O.
    PLOS ONE, 2017, 12 (11):
  • [44] Effect of Intravitreal Aflibercept on Diabetic Retinopathy Severity and Visual Function in Subjects with Proliferative Diabetic Retinopathy
    Nittala, Muneeswar Gupta
    Alagorie, Ahmed Roshydy
    Velaga, Swetha Bindu
    Zhou, Brenda
    Rusakevich, Alexander Michael
    Wykoff, Charles Clifton
    Ip, Michael S.
    Sadda, Srinivas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [45] Vitreous and serum VEGF levels after intravitreal injection of bevacizumab, ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy
    Sozen-Delil, F. I.
    Cekic, O.
    Haklar, G.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [46] Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
    Li, Siying
    Tang, Jiyang
    Han, Xinyao
    Wang, Zongyi
    Zhang, Linqi
    Zhao, Mingwei
    Qu, Jinfeng
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (05) : 1833 - 1845
  • [47] Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma
    Lu, Qianyi
    Zou, Chen
    Cao, Hui
    Zhao, Minjie
    Yu, Siqing
    Qiu, Qinghua
    Xu, Xun
    Zheng, Zhi
    ACTA OPHTHALMOLOGICA, 2016, 94 (04) : 414 - 415
  • [48] APELIN IN EPIRETINAL FIBROVASCULAR MEMBRANES OF PATIENTS WITH RETINOPATHY OF PREMATURITY AND THE CHANGES AFTER INTRAVITREAL BEVACIZUMAB
    Zhang, Yan
    Jiang, Yan-rong
    Lu, Qiang
    Yin, Hong
    Tao, Yong
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (03): : 613 - 620
  • [49] Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy
    Wykoff, Charles C.
    Eichenbaum, David A.
    Roth, Daniel B.
    Hill, Lauren
    Fung, Anne E.
    Haskova, Zdenka
    OPHTHALMOLOGY RETINA, 2018, 2 (10): : 997 - 1009
  • [50] Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
    Siying Li
    Jiyang Tang
    Xinyao Han
    Zongyi Wang
    Linqi Zhang
    Mingwei Zhao
    Jinfeng Qu
    Ophthalmology and Therapy, 2022, 11 : 1833 - 1845